glp-1 and alzheimer's disease Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders GLP-1 drugs failed to slow

Dietitians noted that patients often do not understand how these therapies work

MS analyses were performed by the Proteomics Research Infrastructure (PRI) at the University of Copenhagen (UCPH), supported by the Novo Nordisk Foundation (NNF) (grant number NNF19SA0059305)

By understanding how the body responds to weight loss and making the necessary adjustments, you can continue to progress toward your health goals

## Telehealth Options Washington state permits telehealth prescribing by licensed providers

baseline glucagon concentrations were similar between controls and subjects with dumping syndrome, and the glucagon levels peaked and remained elevated after 20 minutes in subjects with dumping syndrome